CRYSTALLIC SALT FORM OF (S) - (2- (6-CHLOR-7-METHYL-1H-BENZO [D] IMIDAZOL-2-YL) -2-METHYLPYRROLIDIN-1-YL) (5-METHOXY-2- (2H- 1,2,3-TRIAZOL-2-YL) PHENYL) METHANON AS OREXIN RECEPTOR ANTAGONIST

• 收藏
• 分享

专利权人:

Idorsia Pharmaceuticals Ltd

发明人:

BOSS, Christoph,BROTSCHI, Christine,GUDE, Markus,HEIDMANN, Bibia,SIFFERLEN, Thierry,VON RAUMER, Markus,WILLIAMS, Jodi T.

申请号：

DK14824108

公开号：

DK3077390T3

申请日:

2014.12.02

申请国别(地区):

DK

年份:

2017

代理人:

摘要：

The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/